OR WAIT null SECS
April 20, 2015
The combination of two mAb drugs eradicated a large tumor, but also sparked new toxicity concerns associated with immunotherapies.
GSK notifies CDC and FDA that it is recalling the remaining doses of its 2014–2015 flu vaccine, Flulaval Quadrivalent Thimerosal-free Pre-Filled Syringes, due to decreased potency.
April 17, 2015
The acquisition expands Sartorius Stedim Biotech’s service portfolio.
April 16, 2015
The growing threat and spread of antimicrobial resistance continue to ring alarm bells worldwide.
April 14, 2015
The single-use clarification system eliminates centrigues; harvesting can be performed in one step; and process robustness and predictability are ensured.
Spending on prescription medications reached $373.9 billion in 2014, representing the largest increase in 13 years.
Hydra Biosciences enters into an agreement with Boehringer Ingelheim to research and develop small-molecule TRP inhibitors for renal diseases and disorders.
April 10, 2015
As the prevalence of falsified medicines continues to increase, Switzerland is taking measures to secure its supply chain such as the implementation of serialization.
FDA issues a Warning Letter to Hospira S.p.A. for GMP violations at the company’s Liscate, Italy facility.
Baxter voluntarily recalls select lots of IV solutions due to possible particulate matter.